Literature DB >> 30006835

Prevalence and predictors of blood transfusion after pediatric kidney transplantation.

Katherine M Richards1, Rebecca A Spicer2, Elizabeth Craig2, Sean E Kennedy3,4.   

Abstract

BACKGROUND: Blood transfusion after kidney transplant carries a risk of sensitization to the graft as well as blood borne infections. The aim of this study was to describe the prevalence of blood transfusions in pediatric recipients of kidney transplants and to determine the factors associated with transfusions during the perioperative period. Additionally, to describe the changes in hemoglobin levels during the first 12 months following transplant.
METHOD: A retrospective, single center analysis using data collected prospectively between 2010 and 2017. Red blood cell transfusion within the first week after transplant and anemia at 3 months were used as outcomes. Multivariate analysis was performed on significant variates with results described according to odds ratio (OR) and interquartile range (IQR).
RESULTS: Transfusions were given after 21 of 42 (50%) transplants in recipients aged between 1 and 17 years (median 14 years). Age, height, weight, and pre-transplant hemoglobin predicted transfusion in univariate analyses. Regression analysis identified pre-transplant hemoglobin as an independent factor (OR 0.85, IQR 0.73-0.98; p = 0.02). Anemia was present at 3 months after 15 (36%) transplants. Anemia at 3 months was associated with older and larger recipients, lower pre-transplant hemoglobin, and lower estimated glomerular filtration rate (eGFR) on univariate analysis. Logistic regression analysis identified eGFR at 3 months as the only independent predictor of anemia at 3 months (OR 0.93, IQR 0.87-0.99; p = 0.04).
CONCLUSIONS: Transfusions are prevalent in the perioperative period after pediatric kidney transplantation. Lower pre-transplant hemoglobin increases the risk of transfusion. Graft function predicts hemoglobin levels at 3 months.

Entities:  

Keywords:  Anemia; Blood transfusion; Child; Erythropoietin; Kidney transplantation; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 30006835     DOI: 10.1007/s00467-018-4017-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis.

Authors:  Nassim Kamar; Lionel Rostaing; Sophie Ignace; Emmanuel Villar
Journal:  Clin Transplant       Date:  2011-11-09       Impact factor: 2.863

2.  First confirmed case of transfusion-transmitted hepatitis E in Australia.

Authors:  Veronica C Hoad; Tristan Gibbs; Madhur Ravikumara; Monica Nash; Avram Levy; Samantha L Tracy; Catherine Mews; Zofia Perkowska-Guse; Helen M Faddy; Scott Bowden
Journal:  Med J Aust       Date:  2017-04-17       Impact factor: 7.738

Review 3.  Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Marcello Tonelli; Amit X Garg; Fabio Pellegrini; Pietro Ravani; Meg Jardine; Vlado Perkovic; Giusi Graziano; Richard McGee; Antonio Nicolucci; Gianni Tognoni; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2010-06-24       Impact factor: 25.391

4.  The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children.

Authors:  Jeffrey A Fearon; Joel Weinthal
Journal:  Plast Reconstr Surg       Date:  2002-06       Impact factor: 4.730

5.  Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry.

Authors:  Leah A Krischock; Karlijn J van Stralen; Enrico Verrina; E Jane Tizard; Marjolein Bonthuis; György Reusz; Farida K Hussain; Augustina Jankauskiene; Gregor Novljan; Brankica Spasojević-Dimitrijeva; Ludmila Podracka; Vera Zaller; Kitty J Jager; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2015-09-18       Impact factor: 3.714

6.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

7.  Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA Antibodies.

Authors:  I Ferrandiz; N Congy-Jolivet; A Del Bello; B Debiol; K Trébern-Launay; L Esposito; D Milongo; G Dörr; L Rostaing; N Kamar
Journal:  Am J Transplant       Date:  2016-04-19       Impact factor: 8.086

8.  Effects of blood transfusions given after renal transplantation.

Authors:  Juan C Scornik; Jesse D Schold; Michael Bucci; Herwig-Ulf Meier-Kriesche
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

Review 9.  Measurement and estimation of GFR in children and adolescents.

Authors:  George J Schwartz; Dana F Work
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

Review 10.  HLA sensitisation: can it be prevented?

Authors:  Lesley Rees; Jon Jin Kim
Journal:  Pediatr Nephrol       Date:  2014-07-26       Impact factor: 3.714

View more
  1 in total

1.  Transfusion Status in Liver and Kidney Transplantation Recipients-Results from Nationwide Claims Database.

Authors:  Boyoung Park; Junghyun Yoon; Han Joon Kim; Yun Kyung Jung; Kyeong Geun Lee; Dongho Choi
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.